![Eyal Attar](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Eyal Attar
Keine laufenden Positionen mehr
Profil
Eyal C.
Attar formerly worked at Agios Pharmaceuticals, Inc., as Senior Medical Director from 2016 to 2019, Harvard Medical School, as Member-Leukemia Center, Aprea Therapeutics, Inc., as Chief Medical Officer & Senior Vice President, and Vor Biopharma, Inc., as Chief Medical Officer from 2022 to 2025.
Dr. Attar received his doctorate degree from UNC School of Medicine.
Ehemalige bekannte Positionen von Eyal Attar
| Unternehmen | Position | Ende |
|---|---|---|
| VOR BIOPHARMA INC. | Technik-/Wissenschafts-/F&E-Leiter | 18.04.2025 |
| AGIOS PHARMACEUTICALS, INC. | Technik-/Wissenschafts-/F&E-Leiter | 01.01.2019 |
Harvard Medical School
 Harvard Medical School Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | - |
| APREA THERAPEUTICS, INC. | Technik-/Wissenschafts-/F&E-Leiter | - |
Ausbildung von Eyal Attar
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
45
Beziehungen ersten Grades
5
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 5 |
|---|---|
Agios Pharmaceuticals, Inc.
 Agios Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Discovers and develops therapeutics | Health Technology |
Harvard Medical School
Harvard Medical School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
UNC School of Medicine
 UNC School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Vor Biopharma, Inc.
 Vor Biopharma, Inc. BiotechnologyHealth Technology Engages in developing cell therapies | Health Technology |
Aprea Therapeutics, Inc.
 Aprea Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as biopharmaceutical company which develops novel anticancer compounds | Health Technology |
